Probing the Probes: Fitness Factors For Small Molecule Tools

Slides:



Advertisements
Similar presentations
Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB Sonja Baumli, Jane A. Endicott, Louise N. Johnson Chemistry & Biology Volume 17, Issue.
Advertisements

Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews Chemistry &
Inhibition of Hsp90 with Synthetic Macrolactones: Synthesis and Structural and Biological Evaluation of Ring and Conformational Analogs of Radicicol Nicolas.
In Vivo Photoswitchable Flow Cytometry for Direct Tracking of Single Circulating Tumor Cells Dmitry A. Nedosekin, Vladislav V. Verkhusha, Alexander V.
Biocompatible Quantum Dots for Biological Applications Sandra J. Rosenthal, Jerry C. Chang, Oleg Kovtun, James R. McBride, Ian D. Tomlinson Chemistry &
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates Bradley Croy Doak, Bj ӧ rn Over, Fabrizio Giordanetto, Jan Kihlberg.
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs Yves Pommier, Elisabetta Leo, HongLiang Zhang, Christophe Marchand Chemistry.
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target Alexei F. Kisselev, Wouter A. van der Linden, Herman S. Overkleeft Chemistry & Biology.
Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases Xun Shang, Fillipo Marchioni, Nisha Sipes, Chris R. Evelyn, Moran Jerabek-Willemsen,
Titration-Based Screening for Evaluation of Natural Product Extracts: Identification of an Aspulvinone Family of Luciferase Inhibitors Patricia G. Cruz,
LDAI-Based Chemical Labeling of Intact Membrane Proteins and Its Pulse-Chase Analysis under Live Cell Conditions Takayuki Miki, Sho-hei Fujishima, Kazuhiro.
The Efficacy of siRNAs against Hepatitis C Virus Is Strongly Influenced by Structure and Target Site Accessibility Selena M. Sagan, Neda Nasheri, Christian.
Glycosidase Inhibition by Macrolide Antibiotics Elucidated by STD-NMR Spectroscopy Ali Sadeghi-Khomami, Michael D. Lumsden, David L. Jakeman Chemistry.
Functional Studies of Plasmodium falciparum Dipeptidyl Aminopeptidase I Using Small Molecule Inhibitors and Active Site Probes Edgar Deu, Melissa J. Leyva,
D. Grahame Hardie, Fiona A. Ross, Simon A. Hawley  Chemistry & Biology 
An Unnatural PIP Simulates Growth Factor Signaling
Volume 22, Issue 5, Pages v-vi (May 2015)
Enzyme Annotation with Chemical Tools
“Seeing” the Invisibles at the Single-Molecule Level
Antibiotics: A New Hope
Volume 22, Issue 11, Pages (November 2015)
Probing the Probes: Fitness Factors For Small Molecule Tools
Chemical Proteomics of Host-Pathogen Interaction
Matthieu Desroses, Mikael Altun  Cell Chemical Biology 
Finding the Missing Code of RNA Recognition by PUF Proteins
The Case of the Disappearing Drug Target
Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity  Kenichi.
JAK3 Specific Kinase Inhibitors: When Specificity Is Not Enough
Activity-Based Profiling of 2-Oxoglutarate Oxygenases
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Volume 46, Issue 5, Pages (June 2012)
William J. Zuercher, Jonathan M. Elkins, Stefan Knapp 
A Noncanonical Path to Mechanism of Action
Bioactive Cell-Penetrating Peptides: Kill Two Birds with One Stone
Volume 24, Issue 8, Pages e7 (August 2017)
No Need To Be Pure: Mix the Cultures!
How Chemoproteomics Can Enable Drug Discovery and Development
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
Activity-Based Profiling for Drug Discovery
Miquel Duran-Frigola, Patrick Aloy  Chemistry & Biology 
Ins and Outs of Kinase DFG Motifs
Volume 19, Issue 6, Pages (June 2012)
Chemical Genomic Approaches to Study Model Microbes
Volume 20, Issue 7, Pages (July 2013)
HAT Trick: p300, Small Molecule, Inhibitor
BCR-ABL1 Kinase: Hunting an Elusive Target with New Weapons
PARP Inhibitors: Staying on Target?
Volume 21, Issue 11, Pages (November 2014)
Making a New Turn In Matrix Metalloprotease Inhibition
Volume 15, Issue 12, Pages (December 2008)
Volume 17, Issue 2, Pages (February 2010)
Volume 15, Issue 12, Pages (December 2008)
Jae Won Chang, Daniel K. Nomura, Benjamin F. Cravatt 
A Direct Inhibitor of HMGB1 Cytokine
Screening for a Diamond in the Rough
D. Grahame Hardie, Fiona A. Ross, Simon A. Hawley  Chemistry & Biology 
Matthias P. Müller, Daniel Rauh  Cell Chemical Biology 
L-DOPA Ropes in tRNAPhe
Richard D. Perrins, Giuseppe Cecere, Ian Paterson, Gerard Marriott 
Harnessing the Antioxidant Power with ARE-Inducing Compounds
Wilbert Bitter, Coen Kuijl  Cell Host & Microbe 
Volume 21, Issue 9, Pages (September 2014)
Volume 21, Issue 7, Pages (July 2014)
The Platelet as a Model for Chemical Genetics
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Tools to Tackle Protein Acetylation
Features of Selective Kinase Inhibitors
Volume 21, Issue 9, Pages (September 2014)
Targeting Protein Stability with a Small Molecule
Presentation transcript:

Probing the Probes: Fitness Factors For Small Molecule Tools Paul Workman, Ian Collins  Chemistry & Biology  Volume 17, Issue 6, Pages 561-577 (June 2010) DOI: 10.1016/j.chembiol.2010.05.013 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 Fitness Factors for Chemical Probes Grouped into Four Distinct Areas Chemical properties, biological potency, biological selectivity, and context of use (A), that encompass suggested criteria for evaluating the suitability of chemical probe compounds for exploratory biology (see Baell and Holloway, 2010; Cohen, 2009; Edwards et al., 2009; Frye, 2010; Inglese et al., 2007; Kodadek, 2010; McGovern et al., 2003; Oprea et al., 2007; Rishton, 2003). Threshold values that have been suggested in the literature are tabulated for each of the criteria (B), and a comparison of these properties for drugs, leads, and probes can be found in Table 1. We suggest that although not all probes can, or need to, reach these thresholds in every case, consideration of the criteria will allow a robust assessment of whether the probe is fit-for-purpose, and foster an appreciation of the risk carried forward if significant criteria are not met. Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 Fitness Factors for Chemical Probes Grouped into Four Distinct Areas Chemical properties, biological potency, biological selectivity, and context of use (A), that encompass suggested criteria for evaluating the suitability of chemical probe compounds for exploratory biology (see Baell and Holloway, 2010; Cohen, 2009; Edwards et al., 2009; Frye, 2010; Inglese et al., 2007; Kodadek, 2010; McGovern et al., 2003; Oprea et al., 2007; Rishton, 2003). Threshold values that have been suggested in the literature are tabulated for each of the criteria (B), and a comparison of these properties for drugs, leads, and probes can be found in Table 1. We suggest that although not all probes can, or need to, reach these thresholds in every case, consideration of the criteria will allow a robust assessment of whether the probe is fit-for-purpose, and foster an appreciation of the risk carried forward if significant criteria are not met. Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Fitness Factor Liabilities for Selected Early Chemical Probe Inhibitors of Protein Kinases, the PI3K Family of Lipid Kinases and the HSP90 Molecular Chaperone Important fitness factors that have been improved significantly in subsequent chemical probes and clinical agents acting on these targets have been flagged. The symbols refer to the fitness factors listed in Figure 1, and the evolution of the probes to remove the liabilities shown is discussed in detail in the respective sections of the text. Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 Structures of Selected Protein Kinase Chemical Probes Discussed in Detail in the Text with Their Main Proposed Targets Indicated Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 4 Evolution of Increasingly Selective PKC Inhibitors Based on Staurosporine Percentage inhibitions for UCN-01 and ruboxistaurin were measured at 0.01 μM and 0.1 μM concentrations, respectively, for the same panel of 69 kinases (Bain et al., 2007). IC50 values were determined for sotrastaurin in a panel of 32 kinases (Wagner et al., 2009). The cluster of potent activities for sotrastaurin represents PKC isoform inhibition. All three compounds inhibit several PKC isoforms with IC50 0.001–0.01 μM. Kinase dendrogram (Manning et al., 2002) reproduced courtesy of Cell Signaling Technology, Inc. (www.cellsignal.com). Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 5 Structures of Selected PI3 Kinase and HSP90 Chemical Probes Discussed in Detail in the Text with Their Main Proposed Targets Indicated Chemistry & Biology 2010 17, 561-577DOI: (10.1016/j.chembiol.2010.05.013) Copyright © 2010 Elsevier Ltd Terms and Conditions